Akso Health Group (NasdaqCM:AHG) has changed its independent registered public accounting firm, with the audit committee dismissing Onestop Assurance PAC and appointing CHI-LLTC, a governance-focused move that can reshape how investors view its reporting.

The auditor change comes as the stock trades at US$1.53, with the share price down 22.73% over the past month but up 13.50% over 90 days. The 3 year total shareholder return is very large, which may indicate that momentum has cooled recently.

If this governance shift has you rethinking where you want exposure, it can be useful to compare Akso with other healthcare focused opportunities using our 34 healthcare AI stocks.

With Akso Health Group’s shares at US$1.53, recent short term weakness and a very large 3 year total return raise a key question: is the stock now looking cheap, or is the market already pricing in future growth?

Preferred Price-to-Book of 6.6x: Is it justified?

Akso Health Group is trading at a P/B of 6.6x, which screens as expensive both against the broader US Healthcare sector and its direct peer group, even after the recent pullback to $1.53.

The P/B ratio compares the company’s market value to its book value, which is essentially its net assets on the balance sheet. For a business that is currently loss making, investors often lean on P/B to judge how much of a premium the market is placing on its assets and future potential rather than current earnings.

Here, the premium is clear. The US Healthcare industry average sits at 2.3x P/B, while Akso is at 6.6x, almost three times higher. Even against its peer group average of 6.5x, the stock is still slightly more expensive, suggesting the market is already assigning a full valuation to its balance sheet and future prospects at today’s price.

Result: Price-to-book of 6.6x (OVERVALUED)

However, that premium could be challenged if losses persist or if the China-focused healthcare and e-commerce operations fail to scale meaningfully from current revenue levels.

Next Steps

If this all sounds mixed, you do not need to wait to form an opinion. Move quickly, review the data in detail, and weigh the 4 important warning signs.

Looking for more investment ideas?

If Akso has you reconsidering your next move, do not stop here. Broaden your watchlist now or you risk missing opportunities taking shape elsewhere.

• Target resilience by scanning companies that show up in our 66 resilient stocks with low risk scores and may better fit a steadier risk profile.
• Hunt for value by checking stocks highlighted in our 49 high quality undervalued stocks that combine quality fundamentals with prices the market might be overlooking.
• Spot potential early movers using the 25 elite penny stocks with strong financials that stand out for financial strength rather than just low share prices.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.